Literature DB >> 21505092

Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.

Zakir H Sahul1, Rupak Mukherjee, James Song, Jarod McAteer, Robert E Stroud, Donald P Dione, Lawrence Staib, Xenophon Papademetris, Lawrence W Dobrucki, James S Duncan, Francis G Spinale, Albert J Sinusas.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) are known to modulate left ventricular (LV) remodeling after a myocardial infarction (MI). However, the temporal and spatial variation of MMP activation and their relationship to mechanical dysfunction after MI remain undefined. METHODS AND
RESULTS: MI was surgically induced in pigs (n = 23) and cine magnetic resonance (MR) and dual-isotope hybrid single-photon emission CT (SPECT)/CT imaging obtained using thallium-201 and a technetium-99m-labeled MMP targeted tracer ((99m)Tc-RP805) at 1, 2, and 4 weeks post-MI along with controls (n = 5). Regional myocardial strain was computed from MR images and related to MMP zymography and ex vivo myocardial (99m)Tc-RP805 retention. MMP activation as assessed by in vivo and ex vivo (99m)Tc-RP805 imaging and retention studies was increased nearly 4-fold within the infarct region at 1 week post-MI and remained elevated up to 1 month post-MI. The post-MI change in LV end-diastolic volumes was correlated with MMP activity (y = 31.34e(0.48x), P = 0.04). MMP activity was increased within the border and remote regions early post-MI, but declined over 1 month. There was a high concordance between regional (99m)Tc-RP805 uptake and ex vivo MMP-2 activity.
CONCLUSIONS: A novel, multimodality, noninvasive hybrid SPECT/CT imaging approach was validated and applied for in vivo evaluation of MMP activation in combination with cine MR analysis of LV deformation. Increased (99m)Tc-RP805 retention was seen throughout the heart early post-MI and was not purely a reciprocal of thallium-201 perfusion. The (99m)Tc-RP805 SPECT/CT imaging may provide unique information regarding regional myocardial MMP activation and predict late post-MI LV remodeling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505092      PMCID: PMC3140564          DOI: 10.1161/CIRCIMAGING.110.961854

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  28 in total

Review 1.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

Authors:  M G Sutton; N Sharpe
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 2.  Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis.

Authors:  D MacKenna; S R Summerour; F J Villarreal
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

Review 3.  TrueFISP--technical considerations and cardiovascular applications.

Authors:  Friedrich Fuchs; Gerhard Laub; Kuni Othomo
Journal:  Eur J Radiol       Date:  2003-04       Impact factor: 3.528

4.  Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

Authors:  J T Peterson; H Li; L Dillon; J W Bryant
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

5.  Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact.

Authors:  P Gaudron; I Kugler; K Hu; W Bauer; C Eilles; G Ertl
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

6.  Estimation of 3-D left ventricular deformation from medical images using biomechanical models.

Authors:  Xenophon Papademetris; Albert J Sinusas; Donald P Dione; R Todd Constable; James S Duncan
Journal:  IEEE Trans Med Imaging       Date:  2002-07       Impact factor: 10.048

7.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

Authors:  A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

8.  Accuracy and reproducibility of absolute quantification of myocardial focal tracer uptake from molecularly targeted SPECT/CT: a canine validation.

Authors:  Yi-Hwa Liu; Zakir Sahul; Christopher A Weyman; Donald P Dione; Wawrzyniec L Dobrucki; Choukri Mekkaoui; Matthew P Brennan; William J Ryder; Albert J Sinusas
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

Review 9.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

10.  Myocardial infarct expansion and matrix metalloproteinase inhibition.

Authors:  Rupak Mukherjee; Theresa A Brinsa; Kathryn B Dowdy; Amelia A Scott; Julia M Baskin; Anne M Deschamps; Abigail S Lowry; G Patricia Escobar; David G Lucas; William M Yarbrough; Michael R Zile; Francis G Spinale
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

View more
  40 in total

Review 1.  Image-guided therapies for myocardial repair: concepts and practical implementation.

Authors:  Frank M Bengel; Richard T George; Karl H Schuleri; Albert C Lardo; Kai C Wollert
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-05-29       Impact factor: 6.875

2.  Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.

Authors:  Mitchel R Stacy; Yuji Naito; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Chung Chan; Kevin A Rocco; Toshiharu Shinoka; Albert J Sinusas; Christopher K Breuer
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-21       Impact factor: 5.209

Review 3.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

4.  Creation of clinically relevant model of chronic heart failure: Application of multi-modality imaging to define physiology.

Authors:  Stephanie Thorn; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2015-02-20       Impact factor: 5.952

5.  Playing slot to hitting the jackpot in molecular imaging: On probability of uncovering subcellular pathogenesis vs achieving clinical applicability.

Authors:  Hans J de Haas; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2017-03-28       Impact factor: 5.952

6.  Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic 201Tl Single-Photon Emission Computed Tomography/Computed Tomography Imaging for Evaluation of Early Post-Myocardial Infarction Remodeling.

Authors:  Stephanie L Thorn; Shayne C Barlow; Attila Feher; Mitchel R Stacy; Heather Doviak; Julia Jacobs; Kia Zellars; Jennifer M Renaud; Ran Klein; Robert A deKemp; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2019-11-11       Impact factor: 7.792

Review 7.  Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

Authors:  Sven Hermann; Andrea Starsichova; Bianca Waschkau; Michael Kuhlmann; Christian Wenning; Otmar Schober; Michael Schäfers
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

Review 8.  Cardiac macrophages and their role in ischaemic heart disease.

Authors:  Stefan Frantz; Matthias Nahrendorf
Journal:  Cardiovasc Res       Date:  2014-02-05       Impact factor: 10.787

9.  Cardiovascular Risk and Matrix Metalloproteinase Polymorphisms: Not Just a Simple Substitution.

Authors:  Francis G Spinale; Ashley A Sapp
Journal:  Circ Cardiovasc Genet       Date:  2017-12

Review 10.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.